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Interleukin-2 (IL-2) transcription is developmentally restricted to T cells and physiologically dependent on
specific stimuli such as antigen recognition. Prior studies have shown that this stringent two-tiered regulation
is mediated through a transcriptional promoter/enhancer DNA segment which is composed of diverse
recognition elements. Factors binding to some of these elements are present constitutively in many cell types,
while others are signal dependent, T cell specific, or both. This raises several questions about the molecular
mechanism by which IL-2 expression is regulated. Is the developmental commitment of T cells reflected
molecularly by stable interaction between available factors and the IL-2 enhancer prior to signal-dependent
induction? At which level, factor binding to DNA or factor activity once bound, are individual regulatory
elements within the native enhancer regulated? By what mechanism is developmental and physiological
specificity enforced, given the participation ofmany relatively nonspecific elements? To answer these questions,
we have used in vivo footprinting to determine and compare patterns of protein-DNA interactions at the native
IL-2 locus in cell environments, including EL4 T-lymphoma cells and 32D clone 5 premast cells, which express
differing subsets of IL-2 DNA-binding factors. We also used the immunosuppressant cyclosporin A as a
pharmacological agent to further dissect the roles played by cyclosporin A-sensitive factors in the assembly and
maintenance of protein-DNA complexes. Occupancy of all site types was observed exclusively in T cells and
then only upon excitation of signal transduction pathways. This was true even though partially overlapping
subsets of IL-2-binding activities were shown to be present in 32D clone 5 premast cells. This observation was
especially striking in 32D cells because, upon signal stimulation, they mobilized a substantial set of IL-2
DNA-binding activities, as measured by in vitro assays using nuclear extracts. We conclude that binding
activities of all classes fail to stably occupy their cognate sites in IL-2, except following activation ofT cells, and
that specificity of IL-2 transcription is enforced at the level of chromosomal occupancy, which appears to be
an all-or-nothing phenomenon.
Interleukin-2 (IL-2) is an important cytokine that acts on
both T cells and B cells. Its synthesis is developmentally
restricted to a subset of T-helper cells; in these cells, IL-2 is
exclusively expressed as a transient response to stimulation. In
vivo, the appropriate combination of signals to elicit IL-2
expression is usually triggered by antigen recognition (re-
viewed in references 36 and 49). Because much of the regula-
tion of IL-2 is transcriptional (3, 22), the IL-2 gene has been
extensively studied to learn how multiple signal transduction
pathways are integrated to evoke a specific transcriptional
response (45). In this study, we have focused on the mecha-
nisms that control cell type restriction and signal dependence
of IL-2 transcription.
In vivo interactions between sequence-specific DNA-binding
proteins and their cognate DNA regulatory elements have
been described for only a small number of genes. Even within
this limited data pool, substantially different strategies are used
for different genes. At one extreme, a protein-enhancer com-
plex can be preassembled on the DNA but be inactive until
receipt of an appropriate stimulatory signal or signals. This
describes the activation of c-fos transcription in fibroblasts
upon epidermal growth factor treatment (16). At the other
extreme are cases like the myocyte-specific enhancer of the
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muscle creatine kinase gene, which is not occupied by any of
the DNA-binding factors present in the nonexpressing myo-
blast precursors (29). Only when differentiation is triggered by
decreasing levels of growth factors such as fibroblast growth
factor or transforming growth factor beta do multiple regula-
tory factors bind to the enhancer to activate muscle creatine
kinase transcription. Similar diversity can be imagined for the
mechanisms controlling transcription in a cell-type-specific
manner, although in the cases studied so far, including the
immunoglobulin heavy-chain enhancer (9), no protein-DNA
interactions have been detected in nonexpressing cell types.
Since IL-2 expression is governed by both lineage restrictions
that confer cell type competence and transient mechanisms
that depend on activation signals, this gene might employ
either mechanism or elements of both.
The 300 bp immediately upstream of the IL-2 transcriptional
start site contains a minimal promoter/enhancer region which,
as a whole, can drive expression in a stimulation-dependent,
T-cell-restricted fashion (45). It is composed of multiple
individual regulatory elements which, when assayed on their
own, have strikingly different behaviors. The NF-AT recogni-
tion element binds a complex factor assembled in the nucleus
only in activated T cells (38). When multimerized, this element
drives expression that is largely restricted to T cells and is
activation dependent (47). The NF-KB and AP-1 elements also
drive expression in stimulated but not unstimulated T cells (1);
however, these elements are also active and signal responsive
in other cell types (15). Two CACCC motifs likely act as
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constitutive, general elements (5). Finally, the IL-2 regulatory
region contains a site, octamer (OCT)/0AP40, which binds the
relatively ubiquitous octamer family proteins (15, 18), adjacent
to the more restricted, stimulation-dependent OAP40 protein
(44). The OCT/OAP40 unit functions as a T-cell-specific and
stimulation-dependent activator site, though the octamer fac-
tor component is capable of binding to DNA constitutively (1,
18, 44). We and others have previously shown that different
subsets of these factors are mobilized in T cells as a function of
the use of different combinations of stimuli or in T-lineage cells
of different developmental states (5, 8, 14, 19, 23, 30, 33). In
general, conditions that permit activation of only a subset of
factors do not allow IL-2 expression. The importance of
interactions between multiple sites to create the IL-2 transcrip-
tional pattern is also evident from mutational studies. For
example, disrupting individual cis elements, such as the NF-
AT, AP-1, or OCT/OAP40 site, leads to 4- to 20-fold decreases
in expression (7, 17, 32). These data suggest extensive func-
tional collaboration between regulatory elements of diverse
character, but the mechanism of their collaboration is not
known. This functional collaboration could be at the level of
enhancer occupancy by these factors or at the level of factor
activity or a combination of the two.
In this work, we investigate the mechanistic basis of IL-2
regulation by determining the pattern of protein-DNA inter-
actions at the IL-2 locus in living cells. For simplicity, we have
focused on a few well-defined cellular environments in which
the presence of distinct but overlapping spectra of IL-2 DNA-
binding activities are associated with dramatic all-or-none
effects on IL-2 expression. Three different cell types were
compared: lineally related cells which can or cannot be induced
to transcribe IL-2 as well as an unrelated cell type which does
not make IL-2. We also make use of cyclosporin A (CsA) to
test how specific factors affect both establishment and mainte-
nance of an active transcriptional complex. The results indicate
that diverse DNA-binding activities that participate in control-
ling IL-2 expression collaborate at the level of stable occu-
pancy of IL-2 regulatory sequences.
MATERUILS AND METHODS
Cell culture. EL4.E1.F4 (ELM) thymoma cells and 32D clone
5 (32D) premast cells were grown as described in reference 31,
and L cells were grown as described in reference 12. EL4 cells
and 32D cells were induced with 10 ng of 12-0-tetradecanoyl-
phorbol-13-acetate (TPA) per ml and 180 nM A23187. When
inductions were performed in the presence of CsA, CsA was
used at a concentration of 0.5 ,ug/ml.
RNA preparation and measurements. Total RNA was pre-
pared by the guanidinium isothiocyanate-organic extraction
method of Chomczynski and Sacchi (6), and RNase protection
analysis was performed as previously described (24, 26). RNA
probes were as previously described for IL-2 (24), metallothio-
nein I (MT-I) (28), and glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) (41). Five micrograms of total RNA was
used in the IL-2 analysis, 1 ,ug was used in the MT-I analysis,
and 1 ,ug was used in the GAPDH analysis.
In vivo and in vitro DMS-piperidine treatment of DNA.
Adherent L cells were treated as described in reference 28.
EL4 and 32D suspension cells in medium (107 to 108 in 50 ml)
were pelleted at 500 x g for 5 min at room temperature.
Sufficient medium was left behind to allow resuspension of the
cell pellet in a final volume of 1 ml. Cells were transferred to
a 1.5-ml microcentrifuge tube and placed in a 37°C water bath;
10 pul of a freshly made 10% dimethyl sulfate (DMS)-90%
ethanol solution was added, and the sample was mixed by
gentle inversion. After incubation at 37°C for 1 min, cells were
transferred to a tube containing 49 ml of ice-cold phosphate-
buffered saline (PBS) and centrifuged at 500 x g for 5 min at
4°C. The cell pellet was resuspended by gentle pipetting in 1 ml
of ice-cold PBS, 49 ml of additional ice-cold PBS was added,
and the sample was centrifuged at 500 x g for 5 min at 4°C.
The cell pellet was resuspended in 0.3 ml of ice-cold PBS and
then added to 2.7 ml of lysis solution (300 mM sodium
chloride, 50 mM Tris [pH 8.0], 25 mM EDTA [pH 8.0], 200 p.g
of proteinase K per ml, 0.2% sodium dodecyl sulfate). DNA
was prepared as previously described (27). Naked DNA prep-
aration and in vitro DMS treatment were done as described in
reference 28 except that 0.125% DMS for 2 min at room
temperature was used. Subsequent piperidine cleavage was
performed as previously described (27).
LMPCR visualization of genomic footprints. Ligation-medi-
ated PCR (LMPCR)-aided DMS in vivo footprinting was
carried out as detailed previously (12). Note that the activity of
each unit of Vent polymerase as provided by the manufacturer
(New England Biolabs) has increased in the time since the
experiments in reference 12 were done, and thus 0.5 U of Vent
polymerase is now used in the first-strand synthesis, 1.0 U is
used in the PCR amplification step, and 1.0 U is used in
labeling step. Oligonucleotides used in LMPCR to detect
interactions on the noncoding strand of IL-2 were primer 1
(CTATCTCCTCTTGCGTTlT-GTCCACC), primer 2 (TGTC
CACCACAACAGGCTGCTTACAGGT), and primer 3 (CA
CCACAACAGGCTGCTTACAGGTTCAGGATG). Coding-
strand IL-2 oligonucleotides were primer 1 (GGACTTGAGG
TCACTGTGAGGAGTG), primer 2 (CAAGGGTGATAGG
CAGCTCTTCAGCATG), and primer 3 (CAAGGGTGATA
GGCAGCTCTTCAGCATGGGAG). LMPCR hybridization
temperatures for both primer sets were as follows: primer 1,
60°C; primer 2, 69°C; and primer 3, 72°C. The coding-strand
MT-I oligonucleotides were primer 1 (CGGAGTAAGTG
AGCAGAAGGTACTC), primer 2 (GGAGAAGGTACTC
AGGACGTTGAAG), and primer 3 (GAAGGTACTCAGG
ACGTTGAAGTCGTGG). LMPCR hybridization tempera-
tures were as follows: primer 1, 60°C; primer 2, 66°C; and
primer 3, 69°C.
Quantitation of band intensity was performed by using an
LKB UltroScan XL laser densitometer and recording peak
heights. Fixed and dried gels were exposed to XAR-5 film
without an intensifying screen. Multiple exposures of two
independent in vivo footprint experiments were quantitated,
using three scans per lane. Protections and hypersensitivities
indicated in Fig. 4 ranged in intensity from 25 to 65%
protection and from 25% to twofold hypersensitivity in the
induced EL4 cell samples compared with both naked DNA
samples and uninduced EL4 cell samples; these were all
observed in both experiments. Comparison of band intensities
among in vivo samples from nonexpressing cells indicated that
all were within 7%. Not marked in Fig. 4 are several G residues
on the coding strand near - 100 and - 200 which were
between 20 and 25% hyperreactive in all in vivo samples from
nonexpressing cells compared with naked DNA (see text).
Electrophoretic mobility shift assays. Nuclear extracts were
prepared as described previously (40) from the same cell
populations as used in the in vivo footprinting experiments.
The mobility shift assay was performed as described previously
(5), using 5 ,ug of nuclear extract, 0.5 ,ug of poly(dI-dC), and
approximately 5 fmol of the appropriate 32P-labeled oligonu-
cleotide. Antibody supershift experiments were performed as
described previously (5) with anti-CREB serum provided by
Marc Montminy and anti-Fos family and anti-Jun family sera
provided by Rodrigo Bravo. As preimmune serum controls
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FIG. 1. RNase protection analysis of IL-2, MT-I, and GAPDH
transcripts in RNA from the cell populations used in Fig. 2, 3, 4, and
7. RNA from unstimulated ELM cells (lane 1), EL4 cells stimulated
with TPA and A23187 for 7 h (lane 2), EL4 cells stimulated for 7 h in
the presence of CsA (lane 3), unstimulated 32D cells (lane 4), and 32D
cells stimulated with TPA and A23187 for 2 h (lane 5) was used. IL-2
RNA was also easily detected in EL4 cells stimulated for 2 h (data not
shown). Lane 6 contained only 30 p.g of tRNA.
were not provided, we verified the specificity of these reagents
by their lack of reaction with NF-KB and CACCC site-binding
complexes. Oligonucleotides were labeled by end filling with
Klenow polymerase. The sequence of one strand is given for
each oligonucleotide used (bases not present in the IL-2 gene
are in lowercase): distal CACCC (-300 to -278),
gatcTCTCCACCCCAAAGAGGAAAATTgatc; proximal CA
CCC (- 72 to - 52), gatcACATCGTGACACCCCCATATTg
atc; octamer (- 100 to -69), gatcTC'ITlGAAAATATGTGT
AATATGTAAAACATgatc; AP-1 (- 161 to - 143), AATT
CCAGAGAGTCATCAG; TGGGC (-237 to -218), gatcC
ACCTAAGTGTGGGCTAACgatc; NF-KB (-211 to - 192),
AAAGAGGGATFllTCACCTAAAT; distal NF-AT (-289 to
-260), AAGAGGAAAAlTTTGTTTlCATACAGAAGGCG
AAT; and proximal NF-AT (- 147 to - 120), gATCAGAAG
AGGAAAAACAAAGGTAATGCgatc.
RESULTS
To examine the mechanisms used to activate IL-2 transcrip-
tion in T cells as well as mechanisms that may be used to keep
it inactivated in nonexpressing cells, we determined the pattern
of protein-DNA interactions at the IL-2 locus in three different
types of cells. ELM thymoma cells were used as a model IL-2
producer cell type, as 70 to 80% of these cells can be induced
to express IL-2 synchronously (24). Upon stimulation with the
phorbol ester TPA and the calcium ionophore A23187, which
mimic many of the physiological effects of antigen stimulation,
EL4 cells show many of the same gene induction events as
antigen-activated T-helper cells do. As in normal T cells, IL-2
transcriptional induction in EMA cells is sensitive to CsA
treatment (33). To examine why the IL-2 gene is not expressed
in other hematopoietic cell types, 32D premast cells were
chosen because they respond to TPA and ionophore stimula-
tion with some of the same gene induction responses as EL4
cells but fail to induce IL-2 (31, 32). Finally, L-cell fibroblasts
were studied to examine mechanisms that may be used to keep
the IL-2 gene inactivated in nonhematopoietic cells (data not
shown). RNase protection analysis was performed to confirm
the expression pattern of IL-2 in the various cell populations
with and without stimulation (Fig. 1), using the same cell
preparations analyzed in the in vitro DNA binding and in vivo
footprinting experiments described below.
Multiple factors that bind sites in the IL-2 promoter/
enhancer in vitro are present in the nuclei of cells that do and
cells that do not express IL-2. The presence of nuclear factors
that can bind to the IL-2 promoter/enhancer is a prerequisite
for the assembly of a transcription complex on the IL-2 gene in
vivo. Previous studies using in vitro DNA footprinting have
already established that large regions of the IL-2 enhancer can
be bound by nuclear factors from cells that cannot make IL-2,
such as HeLa cells (4, 37). The identity, abundance, and
relevance to IL-2 expression of the factors responsible for such
binding are unknown. To establish the availability of specific
factors implicated in the control of IL-2 expression, nuclear
extracts were prepared from the same EL4 T cells and 32D
premast cell populations examined above. These nuclear ex-
tracts were then tested to monitor and identify the factors
capable of binding sites in the IL-2 promoter/enhancer in vitro
by using gel mobility shift assays. The binding activities de-
tected in EL4 T cells (Fig. 2) can be placed into three
categories: constitutive, stimulation dependent (inducible),
and stimulation dependent but CsA sensitive. Oligonucleotides
CACCC NF-AT
distal prox OCT AP-1 TGGGC NF-kB distal prox
TPA/A23 -+ + -+ + -+ + -+ + -+ + -+ + -+ + -+ +
CsA --+ --+ --+ --+ --+ --+ --+
--+
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FIG. 2. Characterization of nuclear factors present in EL4 T-lymphoma cells by electrophoretic mobility shift assay. Nuclear extracts were
prepared from the same populations used in the RNase protection and in vivo footprinting experiments. The 32P-labeled oligonucleotide used in
each experiment is indicated at the top. Arrowheads and brackets mark the major binding activities, as discussed in the text. The major complex
for either CACCC motif can be competed for by the oligonucleotide containing the other CACCC motif or, even more efficiently, by a consensus
SP1 oligonucleotide (5) (data not shown). The unmarked, inducible lower complex in lane 2 can be competed for by the distal NF-AT
oligonucleotide and represents binding of factors to the portion of the distal NF-AT site present in the distal CACCC oligonucleotide (data not
shown). Additional, faster-migrating complexes were detected in lanes 4 to 6. None were CsA sensitive, and the most prevalent species was
constitutively expressed. In lanes 7 to 9, OAP40-binding activity could not be detected in these experiments, probably because of the abundance
of octamer-binding species in EL4 cell extracts. In lanes 16 to 18, a faster-migrating, minor NF-KB site-binding species which was inducible and
partially CsA sensitive like the major species was detected. In lanes 19 to 24, in addition to the well-characterized, inducible, CsA-sensitive NF-AT
complex (filled arrowheads), a faster-migrating species with similar regulatory characteristics (open arrowheads) was observed for both NF-AT
sites. Additional, constitutive NF-AT motif-binding activities were also detected in these EL4 cells. prox, proximal.
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spanning the CACCC sites in the IL-2 promoter bound nuclear
factors in extracts from all cell preparations (Fig. 2, lanes 1 to
6). The most prominent CACCC activities were neither stim-
ulation dependent nor CsA sensitive. Similarly, the octamer
(NF-IL2A)-binding activities in these cells were neither stim-
ulation dependent nor CsA sensitive (lanes 7 to 9). The
proximal AP-1 site was bound by factors which were inducible
but were not CsA sensitive (lanes 10 to 12). By contrast, both
the distal and proximal NF-AT-binding sites, as seen previ-
ously by others (8, 33), showed stimulation-dependent binding
activity that was highly CsA sensitive (lanes 19 to 24). The
NF-KB site bound inducible factors whose binding activities,
under our conditions, were also much reduced by CsA (lanes
16 to 18). Finally, a newly identified TGGGC element (see
below) bound inducible activities with partial CsA sensitivity
(lanes 13 to 15). Thus, multiple factors capable of binding
regulatory elements in IL-2 DNA are present in the nuclei of
unstimulated, stimulated, and CsA-treated stimulated EL4 T
cells.
Similar assays were done to determine whether factors
recognizing IL-2 regulatory elements were present in the 32D
premast cells before or after excitation of signal transduction
pathways (Fig. 3). 32D cell nuclear extracts contained consti-
tutive activities capable of binding the CACCC and octamer
motifs at levels similar to those in EL4 cells (Fig. 3A, lanes 1 to
9; see below). Both constitutive and signal-responsive factors
in 32D cell extracts bound to the NF-KB and TGGGC sites
(lanes 10 to 15). At both sites, the most prominent of the
inducible complexes were at least as prevalent as those in ELM
cell extracts. 32D cells also contained diverse constitutive and
inducible AP-1-binding activities (Fig. 3B; see below). Thus,
32D cell nuclei contain multiple, sequence-specific factors,
some of which are inducible, that bind elements within the IL-2
regulatory region in vitro.
Although many sites have binding activities in both cell types
examined here, previous studies have shown qualitative dis-
tinctions among protein complexes at some individual IL-2
regulatory elements. Moreover, expression of IL-2 has been
correlated with the relative prevalences of these different
activities (5, 19). Here, comparison of 32D cell factors with
ELM cell factors revealed such differences in the complexes
binding at four sites. First, the two more rapidly migrating
octamer-binding activities found in ELM cells, apparently cor-
responding to the Oct-2 species observed in other cell types
(18), were not observed in 32D cells (Fig. 3A, lanes 7 to 9).
However, this may not be very significant for IL-2 transcrip-
tion, as these species are also absent from subsets of thymo-
cytes which are competent to transcribe IL-2 (5). A second and
potentially more interesting qualitative difference was at the
AP-1 site (Fig. 3B and C). We have previously noted that
although several distinct factors can bind this site, all yield
complexes with similar migration characteristics in band shift
assays (5). These factors can, however, be distinguished by the
use of specific immune reagents. In Fig. 3B and C, antibodies
against CREB (13), Fos family, and Jun family (21) proteins
were used to characterize the complexes binding at this site. As
in thymocytes, the majority of activity in uninduced 32D cells is
immunologically related to the cyclic AMP-responsive CREB
factor (Fig. 3B, lanes 1 and 2, and data not shown). Upon 32D
cell stimulation, an activity that reacted with Fos and Jun
family-specific antisera was induced (Fig. 3B, lanes 3 to 6). By
contrast, extracts from stimulated ELM cells contained rela-
tively little of the CREB-related factor (Fig. 3C, lane 2) and
higher levels of Fos and Jun family activities (Fig. 3B, lane 9;
Fig. 3C, lanes 3 and 4). NF-KB site-binding activities also
differed between 32D and EL4 cells. In addition to an appar-
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FIG. 3. Characterization of nuclear factors present in 32D premast
cells by electrophoretic mobility shift assay as described in the legend
to Fig. 2. To facilitate comparisons, nuclear extracts prepared from
stimulated EL4 cells were examined in parallel with the 32D extracts.
(A) Comparison of factors in unstimulated 32D cell nuclear extracts,
stimulated 32D cell nuclear extracts, and stimulated EL4 cell nuclear
extracts. Arrowheads and brackets mark the major binding activities,
as discussed in the text. prox, proximal. (B and C) Perturbation of
complexes formed at the AP-1 site with specific antisera. For pertur-
bation of gel shift complexes with antibodies against CREB (C), Fos
family (F), and Jun family (J) proteins, samples of nuclear extracts
were preincubated with the appropriate antibodies (13, 21) exactly as
described by Chen and Rothenberg (5). Nuclear extracts prepared
from unstimulated 32D cells (panel B, lanes 1 and 2), stimulated 32D
cells (panel B, lanes 3 to 8), and stimulated EMA cells (panel B, lane 9;
panel C, lanes 1 through 4) were used. Filled arrowheads denote the
major binding species in extracts not exposed to antisera, and open
arrowheads denote the major antibody-reactive supershift complexes.
Neither supershift complexes nor inhibition of binding was observed
when these antibodies were assayed for perturbation of complexes with
the NF-KB site (data not shown). The prevalent, faster-migrating
species in panel B, lane 1, was not observed reproducibly.
ently common major binding species, 32D cells contained
elevated levels of a more rapidly migrating complex. Its
migration characteristics suggest that it may correspond to the
NF-KC activity previously proposed to play a negative role in
IL-2 transcription (19). Finally, gel mobility shift assays showed
that the inducible NF-AT activity observed in EL4 cells is
greatly reduced in 32D cells (Fig. 3A, lanes 16 to 18).
Taken together, the cell type differences and similarities in
individual binding activities emphasize several points. First,
although the difference in NF-AT-binding activity correlates
nicely with the demonstrated importance of its sequence
element for IL-2 transcription, there are numerous other
quantitative and qualitative differences in the sets of binding
factors in 32D cells compared with EL4 cells. Second, these
differences involve not only regulatory factors thought to act
positively but also potential negative regulators. Finally, the
multiplicity of factors suggests that only a subset of the factors
detected in vitro are assembled in the active complex in vivo.
Moreover, the factors that are relevant in vivo may, at least in
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FIG. 4. DMS in vivo footprint of the IL-2 regulatory region. DNA from in vivo DMS-treated unstimulated 32D cells (panel A, lane 1; panel
B, lane 2), stimulated 32D cells (panel A, lane 2; panel B, lane 3), unstimulated EL4 cells (panel A, lane 4; panel B, lane 5), stimulated EL4 cells
(panel A, lane 5; panel B, lane 6), EL4 cells stimulated in the presence of CsA (panel A, lane 6; panel B, lane 7), and EL4 cells stimulated for
2 h prior to the late addition of CsA (panel A, lane 7; panel B, lane 8) was used. Naked 32D DNA (panel B, lane 1) and naked EL4 DNA (panel
A, lane 3; panel B, lane 4), each treated with DMS in vitro, were also used. The in vivo footprint patterns of the coding (A) and noncoding (B)
strands are shown. Location in the sequence ladder with respect to the major start site of IL-2 transcription is indicated at the inside edge of each
panel. Bands marked with arrows were reproducibly more than 25% protected (plain arrow) or more than 25% hypersensitive (arrow with circle)
in induced EL4 cells compared with uninduced EL4 cells and naked EL4 DNA. Weak interactions apparent in the experiment shown but not
reproducibly observed over the multiple independent experiments performed (e.g., a protection near - 100 on the coding strand) are not marked.
An artifactual band not predicted from the sequence of IL-2 (asterisk) was seen when the noncoding-strand primer set was used. It became
approximately 10-fold more intense than any other band in the ladder under LMPCR conditions which gave generally high background (e.g., with
use of excess Vent DNA polymerase; data not shown). Its intensity correlated in no way with the identity of the DNA sample (data not shown).
some cases, be species other than the quantitatively dominant in vivo footprinting was performed by treating intact cells with
ones observed in vitro. the membrane-permeable alkylating agent DMS (9). DMS
Determining the pattern of protein-DNA interactions at the detects proteins bound to DNA at G residues in the major
IL-2 locus in vivo. To detect in vivo protein-DNA interactions, groove. Protein occupancy can protect individual G residues
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CACCC NF-AT 3'NF-AT
f;
octamer
TACTTTTGTG TCTCICCCC AAA|GAGGAAA AtMTTTCA TACAGAAdCC GkTCATTGTA lGAATTAAAA CTGCCACCTA -231
ATGAAAACAC AGAGGGG TTTICTCCTTT 7%AACAAAGT ATGTCTTCIG CS AGTAACAT AGTTAATTTCACGGTGGATt4T~~~~~~~~~~~~~~~~~~~~~~~~~~~
TGGGC NF-KB AP-1 ATGG
-230 AGT G AACCCGACCA A GGGATTT CACCAAATC CA IGT -171TCA TTGGGCTGGT TCTTCATTAG NGTAGCACA cc
CD28RE AP-1 NF-AT
-170 GTTTAAGAA ATTC GAGCA AGAA PAGGAAAA C AAAGGTAATG CTTTCTGCCACAAATTIgTZ TAAGTI TCTT G TTTCCATTAC GAAAGACGGT
0 P40 octamer CACCC TATA-2
-100 CTCTTTGAAA ATATGGTAA TTGTAAAAC AGTGAPCA CCCCAFATTA TTGAGAAACTTT TATA ATT ACATTTTG GCACT'TG GGGIPGMAAT-AbAAGGTCG
I HO O
CACAGGTAGA -101GTGTCCATCT
TATA-1
ATTAACAGTA -31TAATTGT T
-30 ITAAAITGCCT CCCATGCTGA AGAGCTGCCT ATCACCCTTTLATTTAACGGA GGGTACGACT TCTCGACGGA TAGTGGGAAA
FIG. 5. Summary of protein-DNA interactions detected in stimulated EL4 cells. Downward arrows denote protected bases; upward arrows
denote hypersensitive bases. CD28RE, CD28 response element.
within its recognition site from reaction with DMS or, occa-
sionally, render additional G residues within that site hyper-
sensitive to DMS. After alkylation with DMS, subsequent
treatment with piperidine was used to produce DNA cleavage
at the methylated G's. When appropriately visualized, this
results in a G-specific sequence ladder. In parallel, unmodified
DNA was purified from cells and deproteinized, and the naked
DNA was then treated with DMS. DMS footprints were
revealed by comparing the patterns of G cleavage (G ladders)
of DNA treated with DMS within different living cell popula-
tions (in vivo samples) with each other and with the pattern of
G cleavage of naked DNA samples. The DMS footprints,
consisting of protected G residues and associated G hypersen-
sitivities, were visualized by LMPCR genomic footprinting (29)
as described previously (12).
Stimulation of EL4 T cells results in the coordinated
binding of multiple proteins to the IL-2 promoter/enhancer.
The pattern of in vivo protein-DNA interactions at the IL-2
locus was assessed by quantitatively comparing band intensities
in different in vivo DMS-treated and naked DNA samples (Fig.
4). First, note that many sites in the IL-2 promoter/enhancer
showed footprints in EL4 T-lymphoma cells upon induction.
Comparison of the G ladder generated from IL-2-transcribing,
induced EL4 T cells (Fig. 4A, lane 5; Fig. 4B, lane 6) with the
G ladder from the same cells prior to induction (uninduced
EL4 T cells; Fig. 4A, lane 4; Fig. 4B, lane 5) revealed many
differences in DMS reactivity. Each interaction, indicated at
the margins of Fig. 4 and summarized in Fig. 5, involves just a
few specific G residues, as expected for a DMS footprint.
These footprints were highly reproducible in multiple indepen-
dent experiments.
Each interaction corresponds to a sequence-specific binding
activity that can be detected in vitro in an electrophoretic
mobility shift assay, with the exception of one site not yet
tested. In vivo footprints were found at previously identified
NF-AT (both -280 and - 135), AP-1 ( - 150), OCT/OAP40
(-70 to -85), and NF-KB (-200) recognition sites, all of
which have been shown to be functionally important by
cis-element mutagenesis experiments (2, 7, 17, 37, 44). In vivo
footprinting also confirmed the occupancy of a CACCC site
(-294) described elsewhere (5) and revealed interactions at
two previously unidentified elements, a proximal CACCC
motif (-60) and a TGGGC site (-225). The ability of each of
these elements to bind sequence-specific factors from nuclear
extracts in vitro was demonstrated in Fig. 2 and 3. An
additional interaction was detected at an ATGG site (- 175),
which has not yet been examined in vitro. Finally, an interac-
tion was seen between the two IL-2 TATA boxes, which may
reflect the assembly of the basic RNA polymerase II machinery
in that region. Occupancy of all these sites was detectable after
1 h of induction and was maximal by 2 h (Fig. 6A and data not
shown). Representative footprints at the distal NF-AT site, the
NF-KB site, and the proximal AP-1 site after 2 and 5 h of
induction are shown in Fig. 6A. Footprints persisted at maxi-
mal levels until at least 11 h after induction, as shown in Fig. 6B
for the proximal AP-1 site, the proximal NF-AT site, and the
OCT/OAP40 site.
Conversely, several other potential regulatory elements were
not detectably occupied in the major groove in vivo. We failed
to detect contacts at the G residues in the distal octamer motif
at -255, the distal AP-1 motif at - 180, and the region 3' of
the distal NF-AT core at -280 (3' NF-AT site), whose
counterparts in the human gene, though not perfectly homol-
ogous to the murine elements, have been shown to contribute
to the function of the human IL-2 gene (17, 18, 42). In these
cells, no clear evidence was found for the binding of factors to
the CD28 response element either, although protection was
seen at the junction of this site with the proximal AP-1 site.
This is consistent with observations that the CD28 response
element plays no role in IL-2 induction in response to TPA-
A23187 induction in the human Jurkat T-cell line (11). Though
in vivo footprints were performed up to 24 h after induction
(data not shown), no major groove interactions were detected
at the G residues in the putative negative element at - 105,
proposed to decrease induced transcription of the human IL-2
gene by functioning to shut off IL-2 transcription at later time
points (50). Thus, for several potential regulatory elements, we
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FIG. 6. (A) DMS in vivo footprints over representative binding sites at 2 and 5 h of induction. DNA from in vivo DMS-treated uninduced EL4
cells (lane 1), EL4 cells induced for 2 h (lane 2), and EL4 cells induced for 5 h (lane 3) was used. Lane 2 was exposed for 20% longer than lanes
1 and 3 to compensate for underloading of that lane. (B) DMS in vivo footprints over representative binding sites between 4 and 11 h of stimulation.
DNA from in vivo DMS-treated unstimulated EL4 cells (lane 2), EL4 cells stimulated for 4, 7, 9, and 11 h (lanes 3, 4, 6, and 8), and EL4 cells
stimulated in the presence of CsA for 7, 9, and 11 h (lanes 5, 7, and 9) was used. Naked EL4 DNA (lane 1), treated with DMS in vitro, was also
used. The entire set of interactions shown in Fig. 4 was seen in these experiments. All were of equal relative intensity in the induced samples, but
only a subset are shown here.
see no in vivo evidence that they play a role in IL-2 transcrip-
tional regulation in mouse EL4 T cells.
No protein-DNA interactions were detected in unstimulated
EL4 T cells, 32D premast cells, or L cells. In principle, cells
that are not transcribing IL-2 might have stably bound repres-
sors at the IL-2 locus or partially assembled enhancer com-
plexes. Furthermore, a developmentally committed but as yet
uninduced IL-2 producer (EL4 T cell) might reveal its com-
mitted status in the form of a pattern of protein-DNA inter-
actions different from that of an IL-2 nonproducer (32D cell or
L cell). Finally, an activated 32D cell might in principle
assemble partial protein-DNA complexes at the IL-2 locus,
reflecting its partial content of inducible IL-2 DNA-binding
activities. However, we detected no in vivo protein-DNA
interactions in any of the nonexpressing cells examined, includ-
ing unstimulated EL4 T cells, 32D cells, and L cells (data not
shown), as well as stimulated 32D cells. This conclusion was
drawn by comparing the G ladders derived from naked DNA
samples with those from in vivo samples. The naked DNA
samples (Fig. 4A, lane 3; Fig. 4B, lanes 1 and 4) were very
similar to the in vivo samples from cells not actively expressing
IL-2 (Fig. 4A, lanes 1, 2, and 4; Fig. 4B, lanes 2, 3, and 5). The
only changes in DMS reactivity between naked DNA samples
and these in vivo DMS-treated samples were observed on the
coding strand near - 100 and - 200, where several G's were 20
to 25% hyperreactive in all the in vivo samples. However, the
complete absence of associated protections is not typical of
most protein-DNA interactions, and no interactions of any sort
were detected at adjacent bases on the noncoding strand. Such
isolated hypersensitivities have sometimes been encountered
in comparisons of naked DNA versus in vivo DMS-treated
DNA for other genes, and their significance remains unknown
(20, 29). More importantly, all elements in the pattern of
interactions seen in the induced EL4 T cells are entirely absent
in the nonexpressing cells. For example, the NF-KB site is
unoccupied even in stimulated 32D cells, though ample levels
of NF-KB-binding activities (including putative NF-KC) are
present in nuclear extracts from these cells. Furthermore, no
interactions are apparent elsewhere in the IL-2 regulatory
region in nonexpressing cells. This absence of detectable in
vivo binding contrasts with the presence of corresponding
DNA-binding activities in the nuclei of these cells.
CsA treatment entirely blocks protein-DNA interactions in
stimulated ETA T cells. IL-2 transcription can be completely
inhibited by CsA treatment, although individual IL-2 regula-
tory elements show diverse sensitivities to the drug. This could
result from CsA totally blocking the binding of both CsA-
sensitive and -insensitive factors to the DNA or through the
Oct
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elimination of a subset of DNA-bound activators sufficient to
prevent transcription. When EL4 T cells were stimulated with
TPA and A23187 in the presence of CsA, all footprints
associated with IL-2 induction were absent (Fig. 4A, lane 7;
Fig. 4B, lane 8; Fig. 6B, lanes 5, 7, and 9). Thus, CsA blocks the
in vivo binding of all detected factors to the IL-2 regulatory
region, despite affecting the in vitro binding activities of only a
few. Therefore, at least one CsA-sensitive component of the
EM4 response is required for the coordinated binding of all
factors.
The results presented above show that CsA blocks the
establishment of stable occupancy at the IL-2 regulatory
region. We next addressed whether CsA has an effect on the
maintenance of stable occupancy after it has been established.
Addition of CsA to preactivated EL4.E1 cells is known to
abort IL-2 expression almost immediately (38). This effect
might be due to the partial or complete loss of bound factors.
Alternatively, the binding of factors, once established, might be
insensitive to CsA treatment, with delayed CsA treatment
instead inhibiting the ability of these bound factors to activate
transcription. As shown in Fig. 6, maximal levels of regulatory
region occupancy are obtained after 2 h of TPA-A23187
stimulation and persist at these levels for at least an additional
9 h. Thus, CsA was added after 2 h of stimulation ("late" in
Fig. 4). When protein-DNA interactions were examined 7 h
later, the delayed CsA treatment had resulted in the elimina-
tion of all footprints (Fig. 4A, lane 8; Fig. 4B, lane 9). In the
absence of CsA, regulatory region occupancy was still maximal
at this time point. Thus, CsA blocks both the establishment
and the maintenance of the protein-DNA complex at the IL-2
promoter/enhancer.
The absence of in vivo protein-DNA interactions in cells that
do not express IL-2 is gene specific. The conclusion that
unstimulated EL4 T cells, CsA-treated stimulated EL4 T cells,
and 32D cells show none of the in vivo interactions character-
istic of induced T cells required a positive control to show that
the absence of IL-2 footprints is gene specific and not a simple
artifact of toxicity, cell handling, or footprinting manipulations.
This issue was addressed by using the same DNA preparations
to footprint another gene, the MT-I gene, which is expressed in
all of these cell populations (Fig. 1). The characteristic in vivo
footprint at the MT-I locus Spl site was present in all samples
(Fig. 7 and data not shown).
DISCUSSION
Regulation of the IL-2 gene is interesting on several levels.
First, the stringency of its transcriptional regulation is extreme
with respect to its developmental specificity and its rapid
response to specific environmental signals. The well-estab-
lished complexity of IL-2 cis elements and of their cognate
binding activities demands the integration of many less specific
activities. How is this integration accomplished, and what
prevents low-level, leaky expression? To address these issues,
we have determined the nature of in vivo protein-IL-2 gene
complexes and compared them with the sets of nuclear factors
present in an informative group of cell lines. These cell lines
represented different developmental lineages and were studied
under different signal transduction states. A central result was
that the level of regulation which directly correlated with active
IL-2 transcription was enhancer occupancy by all factor types
involved. This appeared to be an all-or-nothing, reversible
phenomenon. Insults to subsets of the binding activities totally
abolished all interactions by those factors that remained
(summarized in Fig. 8). This places the burden of specificity on
stable chromosomal occupancy. If the whole protein-enhancer
32D EL4
+ - + + TPA/A23
co
z - Z - + CsA
___
*
1spi
d -M OM
12 3 4 5 6 7
FIG. 7. DMS in vivo footprint of the Spl-binding site in the MT-I
gene. DNA from in vivo DMS-treated unstimulated 32D cells (lane 2),
stimulated 32D cells (lane 3), unstimulated EL4 cells (lane 5), stimu-
lated EL4 cells (lane 6), and EL4 cells stimulated in the presence of
CsA (lane 7) was used. Naked 32D DNA (lane 1) and naked EL4 DNA
(lane 3), each treated with DMS in vitro, were also used.
complex must be assembled on the DNA in order to achieve
stable occupancy by any subset of the factors, stringent limita-
tions are imposed on when and where transcriptional activa-
tion occurs. We also infer that it is this highly coordinated
assembly that satisfies the biological requirement that the IL-2
enhancer/promoter be robust when activated yet very sensitive
to multiple signal inputs. As discussed below, this provides an
explanation for the previously observed sensitivity of this
enhancer/promoter to mutagenesis of individual elements.
Thus, while it remains possible that the transcription-inducing
activities of some of these factors are also regulated after they
bind to DNA, regulation of stable occupancy dominates.
The study of IL-2 transcriptional control also presents the
potential for separation of developmental restriction from the
actual induction of expression. In this respect, IL-2 differs from
several other developmentally restricted genes that have pre-
viously been studied in this way. In those systems, differentia-
IL-2 REGULATORY REGION
300 NF-AT TGGGC-200 ATGG NF-AT 100 CACCC
CACCC NF-iB AP-1 OAP40/OCT
IN VIVO PROTEIN:DNA INTERACTIONS TRANSCRIPTION
Uninduced EL4 T Cells
No
Induced EL4 T Cells
Yes
Induced, cyclosporin A-treated EL4 T Cells
8 e Gn 4 f
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FIG. 8. Summary of the protein-DNA interactions detected in EL4
T lymphoma cells by in vivo footprint analysis and the presence of
nuclear factors in these cells as determined by in vitro DNA-binding
analysis. Decreased size of TGGGC- and NF-KB-binding activities in
stimulated, CsA-treated EL4 cells depicts the quantitative decrease in
in vitro DNA-binding activity in Fig. 2. OAP40 activity could not be
detected in Fig. 2, but its presence in stimulated EL4 cells was inferred
because of the in vivo methylation protection of a G residue adjacent
to the octamer motif which specifically disrupts OAP40 binding when
methylated (44). Stimulation-dependent OAP40 binding activity has
been detected in the human Jurkat T-cell line, but its CsA sensitivity
was not examined (44). The ATGG site was not assayed for in vitro
binding activity.
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tion of the cell was temporally and physiologically coupled to
expression of the gene; for example, muscle creatine kinase is
expressed upon differentiation of myoblasts into myocytes.
Because differentiation of T-helper cells is separated from
their activation to express IL-2, it seemed possible that in this
system, there might be factor-DNA interaction at the IL-2
locus in T cells prior to activation that would distinguish them
from non-T cells, thereby setting the stage for the induction
event. Alternatively, such developmental marking might take
the form of specific repressing interactions present in non-T
lineages and then removed in T cells. We tested these possi-
bilities by comparing in vivo protein-DNA interactions in T
cells with those in other hematopoietic and nonhematopoietic
cells prior to induction. No evidence was found for stable,
lineage-dependent molecular commitment at the IL-2 locus.
Thus, the cell-specific competence of the IL-2 locus to be
induced could not be detected at the level of protein-DNA
contacts in the major groove. In addition, even a potent
activation cascade could not trigger any protein-DNA contacts
in the nonpermissive developmental environment of the 32D
cells. It is important to recognize that these observations do
not rule out the possibility of repressive or permissive interac-
tions to which DMS was insensitive, such as binding of proteins
in the minor groove or to recognition sites devoid of G
residues. Thus, the possible involvement of factors such as
TCF-1 and TCF-la/LEF-1 (43, 46, 48) remains to be investi-
gated. However, the compelling result is that there was no
evidence, in any nonexpressing cell examined, of in vivo
occupancy of those sites that ultimately do become occupied in
IL-2-expressing T cells. This finding argues strongly against
straightforward competition between activator and repressor
proteins for binding site contacts in the major groove as a way
of enforcing cell-type- and signal-dependent restriction of IL-2
in these cells.
CsA was used as a pharmacological tool to probe separately
the sensitivity of complex establishment and complex mainte-
nance to the presence of CsA-sensitive factors. One or more
CsA-sensitive factors were required for the stable binding of all
factors, a finding consistent with the functional requirement
for CsA-sensitive regulatory elements such as NF-AT deter-
mined by cis-element mutagenesis studies (7, 32, 42). But such
mutational analyses cannot separate a transient need for an
activity from a sustained requirement for it. The possibility that
establishment of an active enhancer-protein complex can be
functionally separated from its ongoing maintenance has prece-
dent. For example, a "hit-and-run"-style mechanism has been
proposed for the tyrosine aminotransferase gene whereby
interaction of the glucocorticoid receptor is apparently tran-
sient, being needed only to initiate hormonally responsive
expression, with other elements driving ongoing maintenance
and activity of the complex (34). By analogy, CsA, which has
been shown to block initial translocation of NF-AT compo-
nents to the nucleus (10), could act on the initiation of
occupancy but not interfere with its maintenance. However,
CsA treatment of cells containing preassembled complexes
clearly showed that these complexes are not stable over the
time course tested. Thus, one or more CsA-sensitive factors
are required for the persistence of stable binding by all other
factors. Furthermore, unless an unknown effect of CsA is the
active disassembly of protein-DNA complexes, the complexes
that we observe in footprints are not static but are instead in a
dynamic equilibrium with nuclear factors. Mechanistically, the
loss of in vivo binding shows that either a CsA-sensitive
factor(s) functions through cooperative binding interactions
with CsA-insensitive factors or, alternatively, if CsA-sensitive
factors regulate the region's accessibility, this opening is
readily reversible and depends on the CsA-sensitive factors for
its persistence.
Within the IL-2 enhancer, we identified new TGGGC and
proximal CACCC elements whose functions can be addressed
in part by reexamining previously published deletion mutant
studies. A nested series of 5' deletion constructs of the mouse
IL-2 gene displayed a fivefold drop in inducibility in EL4 T
cells when 36 bp including the TGGGC motif was eliminated
(37). This region contains no other element which showed an
in vivo interaction in our analysis (Fig. 4). An internal deletion
across the proximal CACCC motif in the human IL-2 gene
decreased activity of the otherwise intact enhancer fivefold,
though this deletion includes the distal TATA box, and
alterations in spacing could have contributed to the effect (7).
Thus the protein-DNA contacts at the newly identified ele-
ments, like those at the previously described elements, appear
to contribute to IL-2 expression.
Either of two models, which are not mutually exclusive,
could explain the coordinated binding observed at the IL-2
locus: cooperative binding or limited site accessibility. Coop-
erative binding interactions between the multiple DNA-bind-
ing proteins that can interact with individual cis elements,
perhaps anchored by a few key factors, would stabilize the
binding of each member of the complex. Such cooperativity
could operate through direct interactions of the DNA-binding
factors with each other as well as through additional, as yet
unidentified proteins which would act through protein-protein
interactions with the DNA-binding factors. At a minimum,
inducible, T-cell-specific, CsA-sensitive factors would be lim-
iting for stable complex assembly, but other factors, not
limiting in any case studied here, could be equally essential.
One cooperative interaction has been already documented
for the IL-2 regulatory region at the OCT/OAP40 element,
where co-occupancy by OAP40 and Oct-1 stabilizes the bind-
ing of Oct-1 (44). Additional evidence also suggests that the
binding of factors to the IL-2 NF-KB element is stabilized when
the adjacent AP-1 site is included in the target DNA sequence
(31). It will now be important to look for such interactions
more broadly between the multiple elements in IL-2. Evidence
consistent with cooperativity as a substantial component of
IL-2 transcriptional control also comes from cis-element mu-
tational analysis, in which individual alteration of any of a
number of different sites strongly decreases overall promoter/
enhancer activity (7, 17, 18, 37, 42, 44). However, those
experiments did not address whether the collaborative effect
was at the level of DNA binding or at the level of transcrip-
tional activation. An additional feature of the IL-2 regulatory
region that may especially favor dependence on cooperative
interactions that, as noted by Hentsch et al. (15), the
multiple sites ln IL-2 for general factors, such as NF-KB and
AP-1, deviate significantly from their respective consensus
sequences. These changes decrease the binding affinity of the
major species detected in gel shifts and may render them
especially dependent on interactions with nearby factors to
bind in vivo.
By contrast, regulated site accessibility is envisioned to
involve the masking of potential binding sites near IL-2 in a
repressed chromatin configuration. In this case, the action of
inducible factors could serve to open the region, thus allowing
all of the proteins to interact with their binding sites. These two
models differ in the roles that they ascribe to activation-
dependent, T-cell-specific, CsA-sensitive factors like NF-AT.
In one case, they are needed as architectural elements that act
strictly in concert with the other factors; in the other case, they
have a unique role which all other interactions depend on and
follow. The disappearance of existing complexes upon the
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delayed addition of CsA is consistent with either model.
However, it does require that if chromatin accessibility alone is
used to regulate protein-DNA contacts at IL-2, the increase in
accessibility must be fully reversible. Further examination of
the relative contributions of binding cooperativity and site
accessibility should reveal the molecular details of the ob-
served coordinated assembly controlling IL-2 transcription.
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